TokenPost

Vivos Targets $3.8 Million Revenue Lift

Cover art for Vivos Targets $3.8 Million Revenue Lift

TL;DR: Vivos Therapeutics targets $3.8 million in additional annual revenue from payer contract renegotiations to achieve positive operating cash flow by early 2027. Vivos Therapeutics aims to boost annual revenue by $3.8 million through payer contract talks by early 2027. Vivos Therapeutics aims to boost annual revenue by $3.8 million through payer contract renegotiations to achieve positive operating cash flow by early 2027.

Nov 17, 2026

From · · 50s

TL;DR: Vivos Targets $3.8 Million Revenue Lift

Vivos Therapeutics aims to boost annual revenue by $3.8 million through payer contract talks by early 2027.

Vivos Therapeutics targets $3.8 million in additional annual revenue from payer contract renegotiations to achieve positive operating cash flow by early 2027. Vivos Therapeutics aims to boost annual revenue by $3.8 million through payer contract talks by early 2027. Vivos Therapeutics aims to boost annual revenue by $3.8 million through payer contract renegotiations to achieve positive operating cash flow by early 2027.

  • Vivos Therapeutics Revenue Target
  • Financial Risks
  • Nasdaq Listing Risk

Read the story version — the same reporting as a swipeable deck of 3 cards.

Read the original on TokenPost

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on vivos therapeutics and related topics.